Categories: HealthDay

FDA OKs 1st Biosimilar to Prevent Chemo-Related Infections

TUESDAY, June 5, 2018 (HealthDay News) — The first biosimilar drug to Neulasta has been approved by the U.S. Food and Drug Administration. Fulphila (pegfilgrastim) is approved for patients with non-myeloid cancer who are receiving myelosuppressive chemotherapy and have symptoms of febrile neutropenia.

A biosimilar drug, generally derived from a living organism, is approved based on clinical evidence that it is “highly similar” to a product that’s already approved by the FDA, and that there are “no clinically meaningful differences” in safety, purity and potency, the agency said.

The most common side effects of Fulphila are pain in the bones, arms and legs. Less common but more serious adverse reactions include the possibility of spleen rupture, severe respiratory problems and allergic reactions, glomerulonephritis, leukocytosis, tumor growth, and “fatal sickle cell crises,” the FDA said.

“We want to make sure that the pathway for developing biosimilar versions of approved biologics is efficient and effective, so that patients benefit from [price] competition to existing biologics once lawful intellectual property has lapsed on these products,” FDA Commissioner Scott Gottlieb, M.D., said in a statement.

Fulphila is produced by Mylan, with U.S. headquarters in Canonsburg, Penn.

More Information

Copyright © 2018 HealthDay. All rights reserved.

Physicians Weekly

Recent Posts

  • Reuters

Philippines revokes Sanofi’s product license for dengue vaccine

MANILA (Reuters) - The Philippines has permanently halted the sale, distribution and marketing of Sanofi's dengue vaccine in the country…

32 mins ago
  • Reuters

Pfizer-Lilly drug shown to help reduce back pain in late-stage trial

(Reuters) - A non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co succeeded in reducing chronic low back…

41 mins ago
  • Reuters

Intercept’s drug for patients with liver fibrosis due to NASH meets main goal

(Reuters) - Intercept Pharmaceuticals Inc said on Tuesday its treatment testing patients with liver fibrosis due to nonalcoholic steatohepatitis (NASH)…

42 mins ago
  • Reuters

Vietnam confirms first African swine fever cases on three farms

By Mai Nguyen HANOI (Reuters) - African swine fever has been detected on three farms in Vietnam, authorities said on…

2 hours ago
  • Reuters

Environmentalists seek tougher EU curbs on Balkan coal power plants

By Maja Zuvela SARAJEVO (Reuters) - Environmentalists urged EU policy makers on Tuesday to take a tougher stance on air…

3 hours ago
  • Reuters

Ireland urges people not to stockpile medicines ahead of Brexit

DUBLIN (Reuters) - Ireland's deputy prime minister on Tuesday called on people not to stockpile medicine before Britain quits the…

3 hours ago
avtomaticheskij-poliv.com.ua

красивые детские платья

www.niko-centre.kiev.ua